MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹682 Cr | ₹436 Cr | ₹354 Cr | ₹280 Cr | ₹245 Cr |
What is the latest Short Term Provisions ratio of MANKIND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹682 Cr |
| Mar2024 | ₹436 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹245 Cr |
How is Short Term Provisions of MANKIND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹682 Cr | 56.52 | |
| Mar2024 | ₹436 Cr | 23.12 | |
| Mar2023 | ₹354 Cr | 26.57 | |
| Mar2022 | ₹280 Cr | 13.98 | |
| Mar2021 | ₹245 Cr | - | |
Compare Short Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹88,467.2 Cr | -1.7% | -3.6% | -21.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.7% |
-3.6% |
-21.6% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses